Biomarkers for Neurological Disease and Dementia
Aries Biotech and Neurovations are merging their expertise in research and development to measure biomarkers of dementia. Additional information for Neurovations, a leader in patient care, medical devices, and clinical research may be found at https://neurovations.com/.
To learn how we can augment your needs, visit Aries Biotech at https://www.ariesbiotechnologies.org
Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit
Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ
Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors https://www.ariesbiotechnologies.com/ Aries Biotechnologies is thrilled to introduce
